The post-translational modification of PP2A has been implicated in the pathogenesis of Alzheimer’s disease (AD), a neurodegenerative disorder with impaired synaptic plasticity[33-37]. This evidence concerns the gene PTPA and early-onset autosomal dominant Alzheimer disease.